Traws Pharma, Inc.TRAWEarnings & Financial Report
Nasdaq · Health Care · Pharmaceutical Preparations
Traws Pharma, Inc. is a clinical-stage biopharmaceutical firm focused on developing innovative targeted therapies for rare, orphan, and underserved patient groups with high unmet medical needs. It operates mainly in North American and European markets, advancing a pipeline of candidates for serious, life-threatening health conditions.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| OrbiMed Advisors LLC | 19.90% | 605.5K | flat | 2024-11-06 |
| Viriom, Inc. | 6.50% | 1.6M | — | 2024-04-08 |
Insider Transactions
Net 90d: +$998.2K · buys $998.2K / sells $0Range:
Action:
Role:
| Insider | Role | Action | ||||
|---|---|---|---|---|---|---|
| 2026-04-16 | ORBIMED ADVISORS LLC | 10% Owner | Buy (open market) | 597.7K | $1.67 | $998.2K |
1–1 of 1